Prevention of Mammary gland defects in experimental congenital adrenal hyperplasia due to inhibition to 3 beta-hydroxysteroid dehydrogenase in rats.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000311:Adrenal Glands / Q000201:enzymology; D000312:Adrenal Hyperplasia, Congenital; D000324:Adrenocorticotropic Hormone / Q000502:physiology; D000818:Animals; D003345:Corticosterone / Q000627:therapeutic use*; D003486:Cyanides / Q000037:antagonists & inhibitors*; D005260:Female; D005262:Feminization / Q000517:prevention & control; D005333:Fetus / Q000187:drug effects; D006913:Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors*; D006965:Hyperplasia; D007535:Isomerases / Q000037:antagonists & inhibitors*; D008297:Male; D008321:Mammary Glands, Animal / Q000002:abnormalities*; D008696:Methandrostenolone / Q000037:antagonists & inhibitors*; D011247:Pregnancy; D051381:Rats; D013739:Testosterone / Q000627:therapeutic use*
D003486:Cyanides; D013739:Testosterone; D000324:Adrenocorticotropic Hormone; D008696:Methandrostenolone; D006913:Hydroxysteroid Dehydrogenases; D007535:Isomerases; D003345:Corticosterone